A Novel Synthesis of Macitentan, an Endothelin Receptor Antagonist

被引：3
|
作者：
Nami, Majid [1 ]
Sovari, Sara Nasiri [2 ]
Haghighatnia, Yaghoub [2 ]
Dabiri, Minoo [1 ]
Salehi, Peyman [3 ]
机构：
[1] Shahid Beheshti Univ, Fac Chem, Tehran 1983963113, Iran
[2] Hasti Aria Shimi Co, Dept Res & Dev, Tehran 1463745481, Iran
[3] Shahid Beheshti Univ, Dept Phytochem, Med Plants & Drugs Res Inst, GC Evin, Tehran 1983963113, Iran
来源：
ORGANIC PREPARATIONS AND PROCEDURES INTERNATIONAL | 2017年 / 49卷 / 03期
关键词：
PULMONARY ARTERIAL-HYPERTENSION; THERAPY; SITAXSENTAN; BOSENTAN;
D O I：
10.1080/00304948.2017.1320921
中图分类号：
O62 [有机化学];
学科分类号：
070303 ; 081704 ;
摘要：
[No abstract available]
引用
收藏
页码：258 / 264
页数：7
相关论文
共 50 条
  • [1] Unique receptor dissociation kinetics of the novel endothelin receptor antagonist macitentan
    Gatfield, John
    Grandjean, Celia Mueller
    Sasse, Thomas
    Steiner, Beat
    Steiner, Pauline
    Iglarz, Marc
    Kauser, Katalin
    Clozel, Martine
    Nayler, Oliver
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [2] Clinical Pharmacokinetics and Pharmacodynamics of the Endothelin Receptor Antagonist Macitentan
    Sidharta, P. N.
    Treiber, A.
    Dingemanse, J.
    CLINICAL PHARMACOKINETICS, 2015, 54 (05) : 457 - 471
  • [3] Clinical Pharmacokinetics and Pharmacodynamics of the Endothelin Receptor Antagonist Macitentan
    P. N. Sidharta
    A. Treiber
    J. Dingemanse
    Clinical Pharmacokinetics, 2015, 54 : 457 - 471
  • [4] Pharmacokinetics of the Novel Dual Endothelin Receptor Antagonist Macitentan in Subjects With Hepatic or Renal Impairment
    Sidharta, Patricia N.
    Lindegger, Nicolas
    Ulc, Ivan
    Dingemanse, Jasper
    JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 54 (03): : 291 - 300
  • [5] The Endothelin Receptor Antagonist Macitentan Inhibits Human Cytomegalovirus Infection
    Landazuri, Natalia
    Gorwood, Jennifer
    Terelius, Ylva
    oberg, Fredrik
    Yaiw, Koon Chu
    Rahbar, Afsar
    Soderberg-Naucler, Cecilia
    CELLS, 2021, 10 (11)
  • [6] The metabolism of the dual endothelin receptor antagonist macitentan in rat and dog
    Treiber, Alexander
    Miraval, Tommaso
    Bolli, Martin H.
    Funel, Jacques-Alexis
    Segrestaa, Jerome
    Seeland, Swen
    XENOBIOTICA, 2016, 46 (03) : 253 - 267
  • [7] Pharmacokinetic and pharmacodynamic evaluation of macitentan, a novel endothelin receptor antagonist for the treatment of pulmonary arterial hypertension
    Sidharta, Patricia N.
    Kraehenbuehl, Stephan
    Dingemanse, Jasper
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2015, 11 (03) : 437 - 449
  • [8] Efficacy and Safety of a Novel Endothelin Receptor Antagonist, Macitentan, in Japanese Patients With Pulmonary Arterial Hypertension
    Tahara, Nobuhiro
    Dobashi, Hiroaki
    Fukuda, Keiichi
    Funauchi, Masanori
    Hatano, Masaru
    Ikeda, Satoshi
    Joho, Shuji
    Kihara, Yasuki
    Kimura, Takeshi
    Kondo, Takahisa
    Matsushita, Masakazu
    Minamino, Tohru
    Nakanishi, Norifumi
    Ozaki, Yukio
    Saji, Tsutomu
    Sakai, Satoshi
    Tanabe, Nobuhiro
    Watanabe, Hiroshi
    Yamada, Hidehiro
    Yoshioka, Koichiro
    Sasayama, Shigetake
    CIRCULATION JOURNAL, 2016, 80 (06) : 1478 - 1483
  • [9] Investigation of the Effects of Ketoconazole on the Pharmacokinetics of Macitentan, a Novel Dual Endothelin Receptor Antagonist, in Healthy Subjects
    Atsmon, Jacob
    Dingemanse, Jasper
    Shaikevich, Dimitri
    Volokhov, Inna
    Sidharta, Patricia N.
    CLINICAL PHARMACOKINETICS, 2013, 52 (08) : 685 - 692
  • [10] Novel Dual Endothelin Receptor Antagonist Macitentan Reverses Severe Pulmonary Arterial Hypertension in Rats
    Kunita-Takanezawa, Mutsumi
    Abe, Kohtaro
    Hirooka, Yoshitaka
    Kuwabara, Yukimitsu
    Hirano, Katsuya
    Oka, Masahiko
    Sunagawa, Kenji
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2014, 64 (05) : 473 - 480
12345